+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cerus Corporation - logo

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.

From
From
Viral Inactivation Global Market Report 2024 - Product Thumbnail Image

Viral Inactivation Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Convalescent Plasma Therapy Global Market Report 2024 - Product Thumbnail Image

Convalescent Plasma Therapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Aortic Aneurysm Global Market Report 2024 - Product Thumbnail Image

Aortic Aneurysm Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Pathogen Reduction Systems Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pathogen Reduction Systems Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 200 Pages
  • Global
From
World Market for Blood Screening, 2022 - Product Thumbnail Image

World Market for Blood Screening, 2022

  • Report
  • January 2022
  • 42 Pages
  • Global
From
Viral Inactivation Market Report and Forecast 2023-2031 - Product Thumbnail Image

Viral Inactivation Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
From
Loading Indicator